XML 29 R42.htm IDEA: XBRL DOCUMENT v2.4.1.9
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Net Loss Per Common Share (Details) (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended 12 Months Ended
Dec. 31, 2014
Sep. 30, 2014
Jun. 30, 2014
Mar. 31, 2014
Dec. 31, 2013
Sep. 30, 2013
Jun. 30, 2013
Mar. 31, 2013
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Numerator:                      
Net income $ 13,126us-gaap_NetIncomeLoss $ 4,284us-gaap_NetIncomeLoss $ 20,422us-gaap_NetIncomeLoss $ 4,022us-gaap_NetIncomeLoss $ 57,886us-gaap_NetIncomeLoss [1] $ 5,542us-gaap_NetIncomeLoss $ 15,382us-gaap_NetIncomeLoss $ (4,758)us-gaap_NetIncomeLoss $ 41,854us-gaap_NetIncomeLoss $ 74,052us-gaap_NetIncomeLoss $ 9,660us-gaap_NetIncomeLoss
Denominator:                      
Weighted average common shares outstanding - Basic (in shares)                 46,252,960us-gaap_WeightedAverageNumberOfSharesOutstandingBasic 45,898,019us-gaap_WeightedAverageNumberOfSharesOutstandingBasic 45,951,276us-gaap_WeightedAverageNumberOfSharesOutstandingBasic
Effect of dilutive shares:                      
Common stock equivalents arising from stock options and ESPP (in shares)                 265,129us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants 458,574us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants 648,661us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants
Restricted stock awards and units (in shares)                 167,056us-gaap_IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends 187,012us-gaap_IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends 283,665us-gaap_IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
Weighted average common shares outstanding - Diluted (in shares)                 46,685,145us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding 46,543,605us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding 46,883,602us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding
Net income (loss) per common share:                      
Basic (in dollars per share) $ 0.29us-gaap_EarningsPerShareBasic $ 0.09us-gaap_EarningsPerShareBasic $ 0.44us-gaap_EarningsPerShareBasic $ 0.09us-gaap_EarningsPerShareBasic $ 1.26us-gaap_EarningsPerShareBasic $ 0.12us-gaap_EarningsPerShareBasic $ 0.34us-gaap_EarningsPerShareBasic $ (0.10)us-gaap_EarningsPerShareBasic $ 0.90us-gaap_EarningsPerShareBasic $ 1.61us-gaap_EarningsPerShareBasic $ 0.21us-gaap_EarningsPerShareBasic
Diluted (in dollars per share) $ 0.28us-gaap_EarningsPerShareDiluted $ 0.09us-gaap_EarningsPerShareDiluted $ 0.44us-gaap_EarningsPerShareDiluted $ 0.09us-gaap_EarningsPerShareDiluted $ 1.24us-gaap_EarningsPerShareDiluted $ 0.12us-gaap_EarningsPerShareDiluted $ 0.33us-gaap_EarningsPerShareDiluted $ (0.10)us-gaap_EarningsPerShareDiluted $ 0.90us-gaap_EarningsPerShareDiluted $ 1.59us-gaap_EarningsPerShareDiluted $ 0.21us-gaap_EarningsPerShareDiluted
Anti-dilutive shares excluded from the calculation of diluted net loss per common share (in shares)                 87,894us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount 140,839us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount 212,941us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
Deferred revenue [Abstract]                      
License fee agreement, term of agreement (in years)                 6 years 4 months 24 days    
Taxes, Other                 4,300us-gaap_TaxesOther 178us-gaap_TaxesOther 406us-gaap_TaxesOther
Accounts receivable [Abstract]                      
Unbilled receivables, current 0us-gaap_UnbilledReceivablesCurrent       92us-gaap_UnbilledReceivablesCurrent       0us-gaap_UnbilledReceivablesCurrent 92us-gaap_UnbilledReceivablesCurrent  
Research and Development [Abstract]                      
Development and operations in the Company’s facilities                 27,891us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost 23,491us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost 21,381us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
PPG OLED Materials Agreement (Note 8)                 10,614oled_ResearchAndDevelopmentCostsIncurredUnderMaterialsAgreement 7,470oled_ResearchAndDevelopmentCostsIncurredUnderMaterialsAgreement 6,170oled_ResearchAndDevelopmentCostsIncurredUnderMaterialsAgreement
Costs incurred under sponsored research agreements                 2,014oled_ResearchAndDevelopmentCostsIncurredUnderSponsoredResearchAgreements 2,671oled_ResearchAndDevelopmentCostsIncurredUnderSponsoredResearchAgreements 2,058oled_ResearchAndDevelopmentCostsIncurredUnderSponsoredResearchAgreements
Scientific Advisory Board compensation                 635oled_ScientificAdvisoryBoardCompensation 583oled_ScientificAdvisoryBoardCompensation 423oled_ScientificAdvisoryBoardCompensation
Research and Development Expense, Total                 $ 41,154us-gaap_ResearchAndDevelopmentExpense $ 34,215us-gaap_ResearchAndDevelopmentExpense $ 30,032us-gaap_ResearchAndDevelopmentExpense
[1] During the three months ended December 31, 2013, the Company released income tax valuation allowances of $59.4 million.